Retinai Medical

Curated by Signal

AI-based solutions for the diagnosis of retinal diseases

Overview

AI-based solutions for the diagnosis of retinal diseases. Specifically, the company uses deep learning to analyze OCT, fundus, and angiography images to detect the presence of pathological biomarkers. Ophthalmologists can use the tool to diagnose and monitor disease progression and response to therapy. Initial applications include diagnosis of age-related macular degeneration and diabetic retinopathy.

Key facts

Founded: 2016
Headquarters: Bern, Switzerland
Stage: Sign up to view
Industry: Health Technology

Business model

1 product or service: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

CorDiFio
Mobile app for monitoring heart health of women
Health TechnologyZurich, Switzerland
Little Monk
Provider of an application for mediation and mindfulness
Health TechnologyGeneve, Switzerland
Caresocius
Provider of software for second opinion for tourists
Health TechnologySwitzerland

About Retinai Medical

What does Retinai Medical do?

AI-based solutions for the diagnosis of retinal diseases.

Where is Retinai Medical headquartered?

Retinai Medical is headquartered in Bern, Switzerland.

When was Retinai Medical founded?

Retinai Medical was founded in 2016.

Which sector is Retinai Medical in?

Retinai Medical operates in Health Technology.

Who are Retinai Medical's competitors?

Companies similar to Retinai Medical include CorDiFio, Little Monk, and Caresocius.